BOI:EPA
Boiron SA
€ १८.०५
arrow_upward
+०.२८%(+०.०५०) 1D
अक्टोबर २१, ०९:२५:०७ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€ १८.१०
High
€ १८.१०
Low
€ १७.८०
Mkt. cap
३१.६७ करोड
Avg. vol.
५.५० हजार
Volume
१.३९ हजार
P/E ratio
११.९७
52-wk high
€ ३२.२५
52-wk low
€ १६.९०
EPS
€ १.५१
Shares outstanding
१.७५ करोड
No. of employees
३ हजार
Open
€ १८.१०
High
€ १८.१०
Low
€ १७.८०
Mkt. cap
३१.६७ करोड
Avg. vol.
५.५० हजार
Volume
१.३९ हजार
P/E ratio
११.९७
52-wk high
€ ३२.२५
52-wk low
€ १६.९०
EPS
€ १.५१
Shares outstanding
१.७५ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Kalkine Media
·
१९ मिनेट पहिले
Is AI-Chip Demand Surging for Nvidia (NASDAQ:NVDA)?
Crypto News
·
१ घण्टा पहिले
BNB Standard to ring Nasdaq opening bell on October 26 under new CEO
Benzinga
·
२७ मिनेट पहिले
Stock Market: Will S&P 500 Open Up or Down Today?
Yahoo Finance
·
१ घण्टा पहिले
The Top 15 Stocks in the S&P 500 Are Now 47% of the Value. In 2000 Bubble, It Was 27%
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA